BWAY Brainsway Ltd

USD 5.05 -0.06 -1.174168
Icon

Brainsway Ltd (BWAY) Stock Analysis and Price Targets

COMMON STOCK | Medical Devices | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 5.05

-0.06 (-1.17)%

USD 0.10B

0.02M

USD 6.00(+18.81%)

USD 6.00 (+18.81%)

Icon

BWAY

Brainsway Ltd (USD)
COMMON STOCK | NSD
USD 5.05
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.10B

USD 6.00 (+18.81%)

USD 5.05

Brainsway Ltd (BWAY) Stock Forecast

Show ratings and price targets of :
USD 6.00
(+18.81%)

Based on the Brainsway Ltd stock forecast from 1 analysts, the average analyst target price for Brainsway Ltd is USD 6.00 over the next 12 months. Brainsway Ltd’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Brainsway Ltd is Slightly Bearish, which is based on 2 positive signals and 3 negative signals. At the last closing, Brainsway Ltd’s stock price was USD 5.05. Brainsway Ltd’s stock price has changed by -6.48% over the past week, -13.08% over the past month and +197.06% over the last year.

No recent analyst target price found for Brainsway Ltd
No recent average analyst rating found for Brainsway Ltd

Company Overview Brainsway Ltd

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, the Asia Pacific, Europe, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive di...Read More

https://www.brainsway.com

Bynet Building, Jerusalem, Israel, 9777518

0

December

USD

USA

Adjusted Closing Price for Brainsway Ltd (BWAY)

Loading...

Unadjusted Closing Price for Brainsway Ltd (BWAY)

Loading...

Share Trading Volume for Brainsway Ltd Shares

Loading...

Compare Performance of Brainsway Ltd Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BWAY

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Brainsway Ltd (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
DXCM
DexCom Inc -2.66 (-1.95%) USD51.34B 103.24 55.96

ETFs Containing BWAY

Symbol Name BWAY's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Brainsway Ltd (BWAY) Stock

Based on ratings from 1 analysts Brainsway Ltd's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.

Unfortunately we do not have enough data on BWAY's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for BWAY is USD 6.00 over the next 12 months. The maximum analyst target price is USD 6 while the minimum anlayst target price is USD 6.

Unfortunately we do not have enough data on BWAY's stock to indicate if its overvalued.

The last closing price of BWAY's stock was USD 5.05.

The most recent market capitalization for BWAY is USD 0.10B.

Based on targets from 1 analysts, the average taret price for BWAY is projected at USD 6.00 over the next 12 months. This means that BWAY's stock price may go up by +18.81% over the next 12 months.

We can't find any ETFs which contains Brainsway Ltd's stock.

As per our most recent records Brainsway Ltd has 0 Employees.

Brainsway Ltd's registered address is Bynet Building, Jerusalem, Israel, 9777518. You can get more information about it from Brainsway Ltd's website at https://www.brainsway.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...